KYUNG NAM PHARM (053950) | AccidentalOrder

KOSDAQ · 1,581 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

31.0B

Rev (2024)

60.8B

Op Inc (2024)

-943M

Net Inc (2024)

8.6B

PBR

0.29

52W

0K~3K

KYUNG NAM PHARM operates in the Pharmaceuticals sector.

Legal name: KYUNG NAM PHARM.CO.,LTD.

In fiscal year 2024, KYUNG NAM PHARM (053950) reported revenue of 60.8 billion KRW, down 11.2% from 68.4 billion KRW a year earlier.

Operating profit was -943 million KRW and net income was 8.6 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 31.0 billion KRW, with a P/B of 0.29.

These figures can be verified in the DART filing (receipt no. 20260318001510).

Year	Rev	Op Inc	Net Inc
2024	60.8B	-943M	8.6B
2023	68.4B	-6.7B	-22.2B
2022	59.0B	-3.4B	-6.8B

3 applicable out of 8 items

Large Shareholding Report (General)

Semi-Annual Report (2026.06)

Checks

3 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: No convertible bonds outstanding.

Capital Increase: 2 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 2 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-20	Large Shareholding Report (General)
2026-08-14	Semi-Annual Report (2026.06)